Statistics

Total Visits

Views
Cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: analysis by age group66

Select a period of time:

Number of views in the range

Views
Cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: analysis by age group25

Views

Views
July 20254
August 20250
September 202516
October 20250
November 20252
December 20251
January 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States19
Brazil2
Argentina1
Costa Rica1
Ireland1
Mexico1
 

Top cities views

Views
Dallas15
Ashburn1
Austin1
Brejinho1
Catanduva1
Dublin1
Puebla City1
San Jose1
San José1
San Juan1